STÄMM
Biomanufacturing everywhere
- Founded
- 2013
- Business Model
- B2B
- Website
- stamm.bio
- Total Funding
- $17.0M
- Last Round
- $17.0M Series AFeb 2022
About
Stämm is an advanced biomanufacturing company developing high-throughput bioprocessing solutions for biologics and cell therapy production. The company combines bioengineering, Bio AI, and continuous bioreactor technology to accelerate cell line development for clinical and commercial manufacturing. Its proprietary continuous bioreactor has been shown to increase antibody productivity by up to 30x in European and American pilots. Stämm also builds AI-powered computational platforms that model cell biomolecular behavior to accelerate wetlab bio-innovation cycles.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account